Although IL-32 is generally considered pro-inflammatory due to its ability to activate NFκB signalling and p38 MAPKs and enhance tumor immunity, it can exert anti-inflammatory effects under certain circumstances (19, 27, 40). Here, IL32 is linked to neoplasm.